SHRF was pleased to be a part of announcing that renowned MS researcher Dr. Michael Levin will be taking up the position of Saskatchewan Research Chair in Multiple Sclerosis (MS) Clinical Research. This morning's announcement welcomed Dr. Levin and his family to Saskatchewan where he will lead research that strives to identify causes, new improved treatments and therapies, and ultimately the cure for MS.
“Saskatchewan Health Research Foundation is proud to be a funding partner of the Saskatchewan Chair in MS Clinical Research," said Patrick Odnokon, Interim CEO of SHRF. “We are confident that Dr. Levin is the right person to do this important research for the benefit of Saskatchewan MS patients and their families.”
The Saskatchewan Research Chairs Program enables partnerships between SHRF and other agencies that have a common interest in attracting, supporting and retaining top-quality research leaders in areas of strategic importance to Saskatchewan, who will generate new knowledge, commit to sharing their knowledge to improve health and health care, and contribute to build capacity and training in their fields.
To learn more about Dr. Levin, the partners involved in supporting this research program and the announcement that took place at the University of Saskatchewan, click here.